Trademark Overview
On Tuesday, February 24, 2026, a trademark application was filed for AIRNEXIS with the United States Patent and Trademark Office. The USPTO has given the AIRNEXIS trademark a serial number of 99668592. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, February 24, 2026. This trademark is owned by AirNexis Therapeutics, Inc.. The AIRNEXIS trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:
Research, development, and formulation of pharmaceuticals for inflammatory and respiratory diseases; pharmaceutical formulation services in the field of inflammatory and respiratory diseases
Pharmaceutical preparations and drugs for the treatment, control, prevention, maintenance, and management of inflammatory and respiratory diseases and symptoms in humans; anti-inflammatory and immunomodulatory pharmaceutical compositions; medications for respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), bronchitis, cystic fibrosis, pneumonia, allergic rhinitis, Idiopathic Pulmonary Fibrosis (IPF), bronchiectasis, chronic cough and other pulmonary disorders; pharmaceutical compositions in the form of tablets, capsules, liquids, aerosols, inhalers, creams, ointments, gels, and injectables; fixed-dose combination pharmaceutical preparations for inflammatory and respiratory diseases and symptoms in humans; combination pharmaceutical preparations comprising two or more active ingredients for inflammatory and respiratory diseases and symptoms in humans; pharmaceutical preparations for use in combination therapy for inflammatory and respiratory diseases an...
